| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/08/2023 | 52.47% | Stephens & Co. | → $17 | Reiterates | Overweight → Overweight |
| 05/10/2023 | 7.62% | Susquehanna | $15 → $12 | Maintains | Positive |
| 04/17/2023 | 34.53% | Stifel | $17 → $15 | Maintains | Buy |
| 03/14/2023 | 43.5% | Susquehanna | → $16 | Reiterates | → Positive |
| 11/04/2022 | 1245.29% | RBC Capital | $175 → $150 | Maintains | Sector Perform |
| 07/08/2022 | 25.56% | Benchmark | → $14 | Initiates Coverage On | → Buy |
| 11/10/2021 | 7.62% | Susquehanna | $11 → $12 | Maintains | Positive |
| 02/19/2021 | -37.22% | JP Morgan | → $7 | Downgrades | Overweight → Neutral |
| 07/30/2020 | -28.25% | Stifel | $7 → $8 | Maintains | Buy |
| 06/24/2020 | -32.74% | Northland Capital Markets | → $7.5 | Initiates Coverage On | → Outperform |
| 04/30/2020 | -28.25% | Susquehanna | $6 → $8 | Maintains | Positive |
| 04/03/2020 | -41.7% | Stephens & Co. | $14 → $6.5 | Reiterates | → Overweight |
| 03/11/2020 | -37.22% | Stifel | $12 → $7 | Upgrades | Hold → Buy |
| 02/18/2020 | 7.62% | Stifel | $14 → $12 | Maintains | Hold |
| 02/18/2020 | 25.56% | Stephens & Co. | $17 → $14 | Maintains | Overweight |
| 02/10/2020 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 01/06/2020 | 52.47% | Scotiabank | → $17 | Upgrades | Sector Perform → Sector Outperform |
| 10/17/2019 | 34.53% | Raymond James | $16 → $15 | Maintains | Outperform |
| 09/24/2019 | 7.62% | Stifel | $11 → $12 | Maintains | Hold |
| 09/12/2019 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 09/06/2019 | -1.35% | Scotiabank | $17 → $11 | Downgrades | Sector Outperform → Sector Perform |
| 08/05/2019 | 79.37% | Raymond James | $21 → $20 | Reiterates | → Outperform |
| 04/25/2019 | 79.37% | Jefferies | → $20 | Initiates Coverage On | → Hold |
| 04/25/2019 | 79.37% | Jefferies | → $20 | Initiates Coverage On | → Hold |
| 04/16/2019 | 79.37% | Stifel | → $20 | Downgrades | Buy → Hold |
| 12/21/2018 | 16.59% | Wells Fargo | $18 → $13 | Maintains | Market Perform |
| 11/02/2018 | 79.37% | Baird | $23 → $20 | Maintains | Neutral |
| 10/19/2018 | 88.34% | Raymond James | $25 → $21 | Maintains | Outperform |
| 09/17/2018 | 142.15% | JP Morgan | $25 → $27 | Maintains | Overweight |
What is the target price for MRC Global (MRC)?
The latest price target for MRC Global (NYSE: MRC) was reported by Stephens & Co. on August 8, 2023. The analyst firm set a price target for $17.00 expecting MRC to rise to within 12 months (a possible 52.47% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for MRC Global (MRC)?
The latest analyst rating for MRC Global (NYSE: MRC) was provided by Stephens & Co., and MRC Global reiterated their overweight rating.
When is the next analyst rating going to be posted or updated for MRC Global (MRC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MRC Global, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MRC Global was filed on August 8, 2023 so you should expect the next rating to be made available sometime around August 8, 2024.
Is the Analyst Rating MRC Global (MRC) correct?
While ratings are subjective and will change, the latest MRC Global (MRC) rating was a reiterated with a price target of $0.00 to $17.00. The current price MRC Global (MRC) is trading at is $11.15, which is within the analyst's predicted range.